Jaji, Absar .

HRN: 17-61-31  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/24/2026
07/30/2026
IV
500mg
Q8
Fistula-in-ano
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: